Exane Derivatives’s Organigram Holdings OGI Stock Holding History

Exane Derivatives’s Portfolio OGI Stock Details OGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$5.48K	Hold	1,500	–	–	﹤0.01%	397
2022 Q1	$9.97K	Hold	1,500	–	–	﹤0.01%	677
2021 Q4	$10.5K	Hold	1,500	–	–	﹤0.01%	590
2021 Q3	$13.8K	Hold	1,500	–	–	﹤0.01%	699
2021 Q2	$17.8K	Hold	1,500	–	–	﹤0.01%	712
2021 Q1	$20.7K	Hold	1,500	–	–	0.01%	565
2020 Q4	$7.96K	Hold	1,500	–	–	﹤0.01%	537
2020 Q3	$6.32K	Hold	1,500	–	–	﹤0.01%	489
2020 Q2	$9.29K	Hold	1,500	–	–	﹤0.01%	418
2020 Q1	$12K	Hold	1,500	–	–	﹤0.01%	422
2019 Q4	$18.7K	Sell	1,500 -8,500	-85%	-$100K	﹤0.01%	396
2019 Q3	$137K	Hold	10,000	–	–	0.02%	288
2019 Q2	$258K	Buy	+10,000	New	+$278K	0.05%	234

Other funds holding OGI

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

IIM

Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Exane Derivatives's OGI Position: Q2 2022 in Review

Exane Derivatives held its Organigram Holdings (OGI) position steady in Q2 2022 at 1,500 shares worth $5.48K. The position accounts for ﹤0.01% of the portfolio, ranked #397.

Exane Derivatives first reported a position in OGI in Q2 2019 and has held it in 13 quarters since. The position peaked at $258K in Q2 2019. 141 funds tracked by Wall St. Rank hold OGI as of Q2 2022.

Exane Derivatives held 1,500 shares of Organigram Holdings worth $5.48K as of Q2 2022.
Exane Derivatives left its Organigram Holdings share count unchanged in Q2 2022.
Organigram Holdings made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #397 holding.
Exane Derivatives first reported a position in Organigram Holdings in Q2 2019 and has held it in 13 quarters since.
Exane Derivatives's Organigram Holdings position peaked at $258K in Q2 2019.
141 funds tracked by Wall St. Rank held Organigram Holdings as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.